Drug Deal Disclosure Act requires public release of drug pricing agreements between federal agencies and manufacturers.
The Drug Deal Disclosure Act mandates the Department of Health and Human Services to disclose all documents, communications, and agreements related to most-favored-nation pricing and other confidential drug pricing deals with manufacturers. The Secretary must release this information within 30 days of the Act's enactment. The release must be in a centralized, searchable, and downloadable format. The Act prohibits withholding information based on reputational harm or political sensitivity.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.